This is the authors' abstract. We don't add key points for this paper.
Accumulating evidence supports that, as a critical genome guardian mechanism, the DNA damage response (DDR) is a barrier to early tumorigenesis. As a crucial DDR pathway, Ataxia Telangiectasia Mutated (ATM)-mediated phosphorylation of downstream targets is essential for activation of cell cycle checkpoints, DNA repair, and programed cell death in the presence of DNA damage. 1 Despite extensive biochemical and cellular studies on ATM phosphorylation, these phosphorylation sites are rarely mutated in cancers, challenging the pathophysiological relevance of ATM-mediated phosphorylation in the disease setting.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: